GMO Launches GMO Systematic Investment Grade Credit ETF (INVG)

Fund utilizes factor-based quantitative approach to pursue alpha in investment grade corporate credit

BOSTON--(BUSINESS WIRE)--GMO, a global investment manager known for its long-term, valuation-oriented strategies, today announced the launch of the GMO Systematic Investment Grade Credit ETF (INVG). This actively-managed ETF will employ a systematic, factor-based approach to identify and invest in attractive opportunities within the U.S. investment grade corporate credit market.

Building on GMO's expertise in quantitative investing and credit analysis, INVG will offer investors a differentiated solution for accessing investment grade corporate credit. The strategy is designed to pursue alpha through a blend of factors across value, quality, momentum, and issuer fundamentals, captured through proprietary fair value models, measures of changes in default risk, and momentum signals derived from credit and equity assets.

"The GMO Systematic Investment Grade Credit ETF represents our commitment to providing innovative and differentiated fixed-income solutions in the formats investors and their advisors want," said Scott Hayward, Chief Executive Officer of GMO.

The INVG ETF is designed for investors seeking investment grade corporate credit exposure managed in a systematic, risk-mitigated way.

“Investment grade corporate credit spans all major sectors and offers relatively lower default risk and offers investors access to higher quality corporate balance sheets across the global economy. INVG draws on GMO’s quantitative capabilities with a systematic approach designed to maximize risk-adjusted returns,” said Joe Auth, Head of Developed Fixed Income.

The launch of INVG further expands GMO’s lineup of ETFs, which focused on some of GMO’s highest conviction current ideas and includes GMO U.S. Quality (QLTY), GMO International Quality (QLTI), GMO U.S. Value (GMOV), GMO International Value (GMOI), and GMO Beyond China (BCHI).

More information about GMO's ETFs can be found at: ETF Investing at GMO.

About GMO

Global investment manager GMO, established in 1977, brings together focused expertise within its investment teams, industry-leading research, and client solutions and service to advance clients' goals. Privately owned and renowned for conviction in a valuation-based, long-term investment philosophy, GMO serves sophisticated institutions, financial intermediaries, and families, and managed $65 billion as of March 31, 2025. The firm is headquartered in Boston, with offices in London, Sydney, Amsterdam, Singapore, and Tokyo (representative office). For more information, visit www.gmo.com.

Social Media:
LinkedIn: GMO
X: @GMOInsights

An investor should carefully consider the fund's investment objectives, risks, charges, and expenses before investing. This and other important information can be found in the fund's prospectus. To obtain a prospectus please visit www.gmo.com. Read the prospectus carefully before investing.

Risks associated with investing in the Fund may include: (1) Credit Risk; (2) Market Risk - Fixed Income Investments; (3) Management and Operational Risk. For a more complete discussion of these risks and others, please consult the Fund's Prospectus.

The GMO ETFs are distributed in the United States by Foreside Fund Services LLC. GMO and Foreside Fund Services LLC are not affiliated.